Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II/III Study of Sargramostim in Patients With Coronavirus Disease-2019 (COVID-19)

NCT04642950 is registered in ClinicalTrials.gov with Nobelpharma as lead sponsor.

NCT NCT04642950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04642950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II/III Study of Sargramostim in Patients With Coronavirus Disease-2019 (COVID-19)
Lead sponsor
Nobelpharma
Phase
Phase 2/3
Overall status
Completed
Start date
December 17, 2020
Completion date
October 25, 2021
Enrollment
70 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19